Elizabeth Crowley is VP at Celldex Therapeutics, Inc. (CLDX). They have made 5 open-market trades across 1 company since 2021, most recently 2024-06-14.
CIK 0001681854
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLDX | 9,074 | $250K |
Shares reported on the most recent Form 4, priced at the 2024-06-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDX | SELL | 2024-06-14 | 2024-06-18 | $34.87 | $2.1M | +13.1% | +9.0% | +24.4% |
| CLDX | SELL | 2024-06-07 | 2024-06-11 | $35.06 | $526K | -2.2% | +3.9% | +14.3% |
| CLDX | SELL | 2024-05-30 | 2024-06-03 | $33.64 | $2.6M | +10.8% | +9.2% | +26.2% |
| CLDX | SELL | 2021-12-08 | 2021-12-10 | $40.00 | $160K | +10.5% | -2.9% | -13.6% |
| CLDX | SELL | 2021-11-01 | 2021-11-03 | $43.60 | $298K | -11.1% | -26.3% | -34.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.